nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprostadil—PTGIR—Platelet homeostasis—GUCY1A3—salivary gland cancer	0.0412	0.0412	CbGpPWpGaD
Alprostadil—SLCO2A1—SLC-mediated transmembrane transport—SLC24A3—salivary gland cancer	0.04	0.04	CbGpPWpGaD
Alprostadil—SLCO3A1—SLC-mediated transmembrane transport—SLC24A3—salivary gland cancer	0.0379	0.0379	CbGpPWpGaD
Alprostadil—PTGER2—G alpha (s) signalling events—MC3R—salivary gland cancer	0.0344	0.0344	CbGpPWpGaD
Alprostadil—PTGER2—Ovarian Infertility Genes—ATM—salivary gland cancer	0.0314	0.0314	CbGpPWpGaD
Alprostadil—ABCC4—Ectoderm Differentiation—BCOR—salivary gland cancer	0.0242	0.0242	CbGpPWpGaD
Alprostadil—ABCC4—Platelet degranulation—GAS6—salivary gland cancer	0.0241	0.0241	CbGpPWpGaD
Alprostadil—PTGIR—G alpha (s) signalling events—MC3R—salivary gland cancer	0.0232	0.0232	CbGpPWpGaD
Alprostadil—ABCC4—Response to elevated platelet cytosolic Ca2+—GAS6—salivary gland cancer	0.023	0.023	CbGpPWpGaD
Alprostadil—SLCO2B1—SLC-mediated transmembrane transport—SLC24A3—salivary gland cancer	0.022	0.022	CbGpPWpGaD
Alprostadil—SLCO2A1—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.0203	0.0203	CbGpPWpGaD
Alprostadil—ABCC5—Defective B3GAT3 causes JDSSDHD—ST3GAL4—salivary gland cancer	0.0199	0.0199	CbGpPWpGaD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.0193	0.0193	CbGpPWpGaD
Alprostadil—PTGER2—GPCRs, Class A Rhodopsin-like—MC3R—salivary gland cancer	0.0191	0.0191	CbGpPWpGaD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—MC3R—salivary gland cancer	0.0164	0.0164	CbGpPWpGaD
Alprostadil—SLCO2A1—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	0.0146	0.0146	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—JMJD1C—salivary gland cancer	0.0143	0.0143	CbGpPWpGaD
Alprostadil—ABCC5—Defective B3GAT3 causes JDSSDHD—VCAN—salivary gland cancer	0.0142	0.0142	CbGpPWpGaD
Alprostadil—SLCO3A1—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	0.0138	0.0138	CbGpPWpGaD
Alprostadil—ABCC5—Carbohydrate metabolism—PYGB—salivary gland cancer	0.0136	0.0136	CbGpPWpGaD
Alprostadil—PTGER1—GPCRs, Class A Rhodopsin-like—MC3R—salivary gland cancer	0.0129	0.0129	CbGpPWpGaD
Alprostadil—PTGIR—GPCRs, Class A Rhodopsin-like—MC3R—salivary gland cancer	0.0129	0.0129	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—MC3R—salivary gland cancer	0.0125	0.0125	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.0112	0.0112	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—MC3R—salivary gland cancer	0.0111	0.0111	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—MC3R—salivary gland cancer	0.0111	0.0111	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—GAS6—salivary gland cancer	0.0107	0.0107	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.0107	0.0107	CbGpPWpGaD
Alprostadil—ABCC5—Carbohydrate metabolism—ST3GAL4—salivary gland cancer	0.0107	0.0107	CbGpPWpGaD
Alprostadil—SLCO2A1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00933	0.00933	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—GUCY1A3—salivary gland cancer	0.00924	0.00924	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—GAS6—salivary gland cancer	0.00924	0.00924	CbGpPWpGaD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00885	0.00885	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—JMJD1C—salivary gland cancer	0.00855	0.00855	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—MC3R—salivary gland cancer	0.00842	0.00842	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—MC3R—salivary gland cancer	0.00842	0.00842	CbGpPWpGaD
Alprostadil—SLCO2B1—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	0.008	0.008	CbGpPWpGaD
Alprostadil—ABCC5—Carbohydrate metabolism—NUP62—salivary gland cancer	0.00767	0.00767	CbGpPWpGaD
Alprostadil—ABCC5—Carbohydrate metabolism—VCAN—salivary gland cancer	0.00761	0.00761	CbGpPWpGaD
Alprostadil—ABCC5—Fluoropyrimidine Activity—TP53—salivary gland cancer	0.00754	0.00754	CbGpPWpGaD
Alprostadil—SLCO2A1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.0074	0.0074	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.0074	0.0074	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—ERBB2IP—salivary gland cancer	0.0072	0.0072	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—MC3R—salivary gland cancer	0.00705	0.00705	CbGpPWpGaD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00701	0.00701	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—MC3R—salivary gland cancer	0.0064	0.0064	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—GUCY1A3—salivary gland cancer	0.00551	0.00551	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—GAS6—salivary gland cancer	0.00551	0.00551	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—MYB—salivary gland cancer	0.0055	0.0055	CbGpPWpGaD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K2—salivary gland cancer	0.00541	0.00541	CbGpPWpGaD
Alprostadil—ABCC4—Fluoropyrimidine Activity—TP53—salivary gland cancer	0.00522	0.00522	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00513	0.00513	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.0049	0.0049	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00486	0.00486	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00486	0.00486	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—WNT5B—salivary gland cancer	0.0048	0.0048	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—MC3R—salivary gland cancer	0.00476	0.00476	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—MC3R—salivary gland cancer	0.00476	0.00476	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL17RD—salivary gland cancer	0.00464	0.00464	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—MC3R—salivary gland cancer	0.00432	0.00432	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—MC3R—salivary gland cancer	0.00432	0.00432	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ISYNA1—salivary gland cancer	0.00425	0.00425	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MAML3—salivary gland cancer	0.00424	0.00424	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00407	0.00407	CbGpPWpGaD
Alprostadil—ABCC5—Disease—WNT5B—salivary gland cancer	0.00398	0.00398	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00389	0.00389	CbGpPWpGaD
Alprostadil—ABCC5—Disease—IL17RD—salivary gland cancer	0.00385	0.00385	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CPSF4—salivary gland cancer	0.00385	0.00385	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PYGB—salivary gland cancer	0.00385	0.00385	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MC3R—salivary gland cancer	0.00378	0.00378	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00364	0.00364	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MAML3—salivary gland cancer	0.00352	0.00352	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—MARCKS—salivary gland cancer	0.00347	0.00347	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.0034	0.0034	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—DTX4—salivary gland cancer	0.0033	0.0033	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—MYB—salivary gland cancer	0.00328	0.00328	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—WNT5B—salivary gland cancer	0.00324	0.00324	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—WNT5B—salivary gland cancer	0.00324	0.00324	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PYGB—salivary gland cancer	0.00322	0.00322	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL17RD—salivary gland cancer	0.00313	0.00313	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL17RD—salivary gland cancer	0.00313	0.00313	CbGpPWpGaD
Alprostadil—ABCC5—Disease—ST3GAL4—salivary gland cancer	0.00302	0.00302	CbGpPWpGaD
Alprostadil—SLCO2A1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.00287	0.00287	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MAML3—salivary gland cancer	0.00287	0.00287	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MAML3—salivary gland cancer	0.00287	0.00287	CbGpPWpGaD
Alprostadil—ABCC5—Disease—DTX4—salivary gland cancer	0.00274	0.00274	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FGF16—salivary gland cancer	0.00273	0.00273	CbGpPWpGaD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.00272	0.00272	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00269	0.00269	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PHGDH—salivary gland cancer	0.00263	0.00263	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MC3R—salivary gland cancer	0.00255	0.00255	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MC3R—salivary gland cancer	0.00255	0.00255	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ST3GAL4—salivary gland cancer	0.00253	0.00253	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00246	0.00246	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00246	0.00246	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MAML2—salivary gland cancer	0.00237	0.00237	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—MAP2K2—salivary gland cancer	0.00232	0.00232	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—AQP1—salivary gland cancer	0.0023	0.0023	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FGF16—salivary gland cancer	0.00227	0.00227	CbGpPWpGaD
Alprostadil—PTGER1—G alpha (q) signalling events—PIK3CA—salivary gland cancer	0.00226	0.00226	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—DTX4—salivary gland cancer	0.00223	0.00223	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—DTX4—salivary gland cancer	0.00223	0.00223	CbGpPWpGaD
Alprostadil—ABCC5—Disease—NUP62—salivary gland cancer	0.00217	0.00217	CbGpPWpGaD
Alprostadil—ABCC5—Disease—VCAN—salivary gland cancer	0.00216	0.00216	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—JAG1—salivary gland cancer	0.00203	0.00203	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—CREBBP—salivary gland cancer	0.00202	0.00202	CbGpPWpGaD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—salivary gland cancer	0.00202	0.00202	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FGFR4—salivary gland cancer	0.00202	0.00202	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FBXW7—salivary gland cancer	0.00199	0.00199	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MAML2—salivary gland cancer	0.00197	0.00197	CbGpPWpGaD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—salivary gland cancer	0.00187	0.00187	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FGF16—salivary gland cancer	0.00185	0.00185	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FGF16—salivary gland cancer	0.00185	0.00185	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—NUP62—salivary gland cancer	0.00182	0.00182	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—VCAN—salivary gland cancer	0.00181	0.00181	CbGpPWpGaD
Alprostadil—ABCC5—Disease—JAG1—salivary gland cancer	0.00168	0.00168	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FOXO3—salivary gland cancer	0.00168	0.00168	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FGFR4—salivary gland cancer	0.00167	0.00167	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FBXW7—salivary gland cancer	0.00165	0.00165	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MAML2—salivary gland cancer	0.0016	0.0016	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MAML2—salivary gland cancer	0.0016	0.0016	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.00158	0.00158	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—MAP2K2—salivary gland cancer	0.00156	0.00156	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—MAP2K2—salivary gland cancer	0.00156	0.00156	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.00151	0.00151	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FOXO3—salivary gland cancer	0.00139	0.00139	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—EP300—salivary gland cancer	0.00138	0.00138	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—JAG1—salivary gland cancer	0.00137	0.00137	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—JAG1—salivary gland cancer	0.00137	0.00137	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MAP2K2—salivary gland cancer	0.00137	0.00137	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FGFR4—salivary gland cancer	0.00136	0.00136	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FGFR4—salivary gland cancer	0.00136	0.00136	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FBXW7—salivary gland cancer	0.00134	0.00134	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FBXW7—salivary gland cancer	0.00134	0.00134	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—CREBBP—salivary gland cancer	0.00121	0.00121	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—salivary gland cancer	0.00118	0.00118	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MAP2K2—salivary gland cancer	0.00113	0.00113	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FOXO3—salivary gland cancer	0.00113	0.00113	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FOXO3—salivary gland cancer	0.00113	0.00113	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NOTCH1—salivary gland cancer	0.00112	0.00112	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.00104	0.00104	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—PIK3CA—salivary gland cancer	0.00102	0.00102	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CREBBP—salivary gland cancer	0.00102	0.00102	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—TP53—salivary gland cancer	0.000987	0.000987	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000954	0.000954	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—HRAS—salivary gland cancer	0.000944	0.000944	CbGpPWpGaD
Alprostadil—ABCC5—Disease—NOTCH1—salivary gland cancer	0.00093	0.00093	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MAP2K2—salivary gland cancer	0.000924	0.000924	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MAP2K2—salivary gland cancer	0.000924	0.000924	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000867	0.000867	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CREBBP—salivary gland cancer	0.000843	0.000843	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—EP300—salivary gland cancer	0.000822	0.000822	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—HRAS—salivary gland cancer	0.000802	0.000802	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NOTCH1—salivary gland cancer	0.000757	0.000757	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NOTCH1—salivary gland cancer	0.000757	0.000757	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CCND1—salivary gland cancer	0.000752	0.000752	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PTEN—salivary gland cancer	0.000726	0.000726	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CREBBP—salivary gland cancer	0.000706	0.000706	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—EP300—salivary gland cancer	0.000692	0.000692	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CREBBP—salivary gland cancer	0.000686	0.000686	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CREBBP—salivary gland cancer	0.000686	0.000686	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000645	0.000645	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000645	0.000645	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—PIK3CA—salivary gland cancer	0.000608	0.000608	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PTEN—salivary gland cancer	0.000602	0.000602	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—TP53—salivary gland cancer	0.000588	0.000588	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000585	0.000585	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000585	0.000585	CbGpPWpGaD
Alprostadil—ABCC5—Disease—EP300—salivary gland cancer	0.000574	0.000574	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—HRAS—salivary gland cancer	0.000563	0.000563	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—HRAS—salivary gland cancer	0.000542	0.000542	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—HRAS—salivary gland cancer	0.000542	0.000542	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PIK3CA—salivary gland cancer	0.000512	0.000512	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCND1—salivary gland cancer	0.000508	0.000508	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCND1—salivary gland cancer	0.000508	0.000508	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PTEN—salivary gland cancer	0.000504	0.000504	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TP53—salivary gland cancer	0.000495	0.000495	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PTEN—salivary gland cancer	0.00049	0.00049	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PTEN—salivary gland cancer	0.00049	0.00049	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—EP300—salivary gland cancer	0.000481	0.000481	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—HRAS—salivary gland cancer	0.000474	0.000474	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—EP300—salivary gland cancer	0.000468	0.000468	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—EP300—salivary gland cancer	0.000468	0.000468	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PIK3CA—salivary gland cancer	0.000425	0.000425	CbGpPWpGaD
Alprostadil—ABCC5—Disease—HRAS—salivary gland cancer	0.000393	0.000393	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PIK3CA—salivary gland cancer	0.000356	0.000356	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PIK3CA—salivary gland cancer	0.000346	0.000346	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PIK3CA—salivary gland cancer	0.000346	0.000346	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TP53—salivary gland cancer	0.000335	0.000335	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TP53—salivary gland cancer	0.000335	0.000335	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HRAS—salivary gland cancer	0.00032	0.00032	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HRAS—salivary gland cancer	0.00032	0.00032	CbGpPWpGaD
